Effective for Whom? A Review of Psychological and Social Intervention Recommendations in European Dementia Care Guidelines, Through the Lenses of Social Health and Intersectionality
Authors:
- David NealDavid Neal
- Sara Laureen BartelsSBSara Laureen Bartels
- Saloua Berdai ChaouniSCSaloua Berdai Chaouni
- Thais CaprioliTCThais Caprioli
- Adelina Comas-HerreraACAdelina Comas-Herrera
- Rabih ChattatRCRabih Chattat
- Ana DiazADAna Diaz
- Rose-Marie DroesRDRose-Marie Droes
- Thomas FaulknerTFThomas Faulkner
- Simone Anna FeldingSFSimone Anna Felding
- Manuel Franco-MartinManuel Franco-Martin
- Clarissa GiebelCGClarissa Giebel
Preprint
- 28 February 2025
- preprint
- Published by MDPI AG in Preprints.org
Abstract
In dementia care, access to effective psychosocial interventions is often addressed by evidence-based guidelines for care providers. However, it is unclear if current guidelines consider personal characteristics that may impact intervention effectiveness. This study investigates if, and within what framing, dementia care guidelines in Europe address what is effective and for whom. A review of 47 guidelines from 12 European countries was conducted. Content analysis focused on: i) if guidelines recommended specific psychosocial interventions, and how guidelines referred to ii) social health, iii) intersection of social positioning, and iv) inequities in care or outcomes. Thirty-five guidelines (74%) recommended specific psychosocial interventions. Around half referenced aspects of social health and of intersectionality. Thirteen guidelines (28%) referenced inequities. Social health was not explicitly recognised as a mechanism of psychosocial interventions. Only age and comorbidity were consistently considered to impact interventions’ effectiveness. Inequities were acknowledged to arise from within-country regional variations and individual economic status but not linked to (intersectional) individual societal positions such as sex and/or gender, sexuality, and/or religion. Results between European countries were heterogeneous. Current guidelines offer little insight into what works for whom. Policymakers and guideline developers should work with researchers, generating and translating evidence into policy.Keywords
All Related Versions
This publication has 44 references indexed in Scilit:
- Dementia prevention, intervention, and care: 2024 report of the Lancet standing CommissionThe Lancet, 2024
- The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpointThe Lancet Regional Health - Europe, 2023
- Person-centred long-term care for older persons: a new Lancet CommissionThe Lancet, 2023
- A critical analysis of national dementia care guidancesHealth Policy, 2023
- How do people with dementia make sense of their medications? An Interpretative Phenomenological Analysis studyInternational Journal of Geriatric Psychiatry, 2021
- Toward a theory‐based specification of non‐pharmacological treatments in aging and dementia: Focused reviews and methodological recommendationsAlzheimer's & Dementia, 2020
- The Impact of Young Onset Dementia on Informal Caregivers Compared with Late Onset Dementia: Results from the NeedYD StudyThe American Journal of Geriatric Psychiatry, 2016
- A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the EvidenceDrugs & Aging, 2015
- Systematic review of the body of evidence for the use of biomarkers in the diagnosis of dementiaAlzheimer's & Dementia, 2012
- Guidelines for psychosocial interventions in dementia care: a European survey and comparisonInternational Journal of Geriatric Psychiatry, 2011